Cardiac surgery is the process performed to cure the heart tissue defects, for grafting, or for replacement of heart tissues in case of damage. There are two major types of heart surgeries-closed and open. Aging populations, elevating rates of obesity, poor nutrition, and health stressor majorly drive the market growth. In addition, rapid technological advancement, increase in awareness of the population, and demand for minimally invasive procedures also fuel the market growth. However, excessive cost of cardiac surgical devices and their maintenance is expected to restrain the growth of the market during the forecast period. The global cardiac surgical devices market is accounted for $1,700 million in 2016, and is estimated to reach $2,124 million by 2022, growing at a CAGR of 3.2% during the analysis period (2017-2023). Research Beam Model: Research Beam Product ID: 1545205 5650 USD New
Cardiac Surgical Devices Market Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Cardiac Surgical Devices Market by Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, and Perfusion Disposable), by Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure), and by Age Group (New-born, Infant, Children, and Adults) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Medical Devices
  • Published On : April  2017
  • Pages : 180
 
 

Cardiac surgery is the process performed to cure the heart tissue defects, for grafting, or for replacement of heart tissues in case of damage. There are two major types of heart surgeries-closed and open. Aging populations, elevating rates of obesity, poor nutrition, and health stressor majorly drive the market growth. In addition, rapid technological advancement, increase in awareness of the population, and demand for minimally invasive procedures also fuel the market growth. However, excessive cost of cardiac surgical devices and their maintenance is expected to restrain the growth of the market during the forecast period. The global cardiac surgical devices market is accounted for $1,700 million in 2016, and is estimated to reach $2,124 million by 2022, growing at a CAGR of 3.2% during the analysis period (2017-2023).

The market is segmented on the basis of product type, application, age-group, and geography. By product type, the market is categorized into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Applications covered in the study include congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and others. Based on age group, it is classified into new-born, infant, children, and adults. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS:

  • The study provides an in-depth analysis of the global cardiac surgical devices market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments facilitates to understand various products of the market.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Cardiac Surgical Devices Market Key Segments:

By Product Type

  • Beating Heart Surgery Systems
  • Cardiopulmonary Bypass Equipment
  • Cardiac Ablation Devices
  • Perfusion Disposables

By Application

  • Congenital Heart Defects
  • Cardiac Arrhythmia
  • Coronary Heart Disease
  • Congestive Heart Failure
  • Other Applications

By Age Group

  • New-born (0-30 days)
  • Infant (31 days-1 year)
  • Children (1-18 years)
  • Adult (18+ years)

 By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Others
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of players profiled in the report

  • Edwards Life Science Corporation
  • Medtronic Inc.
  • Getinge Group
  • Atrion Corporation
  • Abbott Laboratories
  • Sorin S.P.A.
  • Terumo Medical Corporation
  • Boston Scientific Corporation
  • Cook Medical
  • Angiodynamics, Inc.

List of other players (These companies are not profiled in the report and same can be done on demand)

  • C. R. Bard, Inc.
  • Trinity Biotech
  • Abiomed, Inc.
  • Cardinal Health
  • CyberHeart Incorporated
  • MedWaves Incorporated
  • Transmedics, Inc.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growing incidence of cardiac diseases
3.5.1.2. Large pool of geriatric population
3.5.1.3. Technological advancements

3.5.2. Restraints

3.5.2.1. High cost of cardiac surgery procedures

3.5.3. Opportunities

3.5.3.1. Lucrative opportunities in emerging economies

CHAPTER 4 CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. BEATING HEART SURGERY SYSTEMS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. CARDIOPULMONARY BYPASS EQUIPMENT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC ABLATION DEVICE

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. PERFUSION DISPOSABLE

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CONGENITAL HEART DEFECTS

5.2.1. Market size and forecast

5.3. CARDIAC ARRHYTHMIA

5.3.1. Market size and forecast

5.4. CORONARY HEART DISEASES

5.4.1. Market size and forecast

5.5. CONGESTIVE HEART FAILURE

5.5.1. Market size and forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size and forecast

CHAPTER 6 CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NEW-BORN POPULATION (0-30 DAYS)

6.2.1. Market size and forecast

6.3. INFANT POPULATION (31 DAYS-1 YEAR)

6.3.1. Market size and forecast

6.4. CHILDREN POPULATION (1-18 YEARS)

6.4.1. Market size and forecast

6.5. ADULT POPULATION (18+ YEARS)

6.5.1. Market size and forecast

CHAPTER 7 CARDIAC SURGICAL DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. China market size and forecast
7.4.5. Japan market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. ANGIODYNAMICS, INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. BOSTON SCIENTIFIC CORPORATION

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. COOK MEDICAL

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. EDWARDS LIFE SCIENCE CORPORATION

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. SORIN S.P.A.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. GETINGE GROUP

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. MEDTRONIC INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. ATRION CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. TERUMO MEDICAL CORPORATION

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL BEATING HEART SURGERY SYSTEMS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL CARDIOPULMONARY BYPASS EQUIPMENT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. GLOBAL CARDIAC ABLATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. GLOBAL PERFUSION DISPOSABLES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CONGENITAL HEART DEFECTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CARDIAC ARRHYTHMIA, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CORONARY HEART DISEASES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CONGESTIVE HEART FAILURE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 13. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR NEW-BORN POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR INFANT POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR CHILDREN POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL CARDIAC SURGICAL DEVICES MARKET FOR ADULT POPULATION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. CARDIAC SURGICAL DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 22. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 24. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 25. EUROPEAN CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 30. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. LAMEA CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP, 2016-2023 ($MILLION)
TABLE 34. ABBOTT: COMPANY SNAPSHOT
TABLE 35. ABBOTT: OPERATING SEGMENTS
TABLE 36. ABBOTT: PRODUCT PORTFOLIO
TABLE 37. ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 38. ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 39. ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 40. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 41. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 42. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 43. COOK: COMPANY SNAPSHOT
TABLE 44. COOK: OPERATING SEGMENTS
TABLE 45. COOK: PRODUCT PORTFOLIO
TABLE 46. EDWARDS LIFE SCIENCE: COMPANY SNAPSHOT
TABLE 47. EDWARDS LIFESCIENCE: OPERATING SEGMENTS
TABLE 48. EDWARDS LIFE SCIENCE: PRODUCT PORTFOLIO
TABLE 49. SORIN: OPERATING SEGMENTS
TABLE 50. SORIN: PRODUCT PORTFOLIO
TABLE 51. GETINGE: COMPANY SNAPSHOT
TABLE 52. GETINGE: OPERATING SEGMENTS
TABLE 53. GETINGE (MAQUET): PRODUCT PORTFOLIO
TABLE 54. MEDTRONIC: COMPANY SNAPSHOT
TABLE 55. MEDTRONIC: OPERATING SEGMENTS
TABLE 56. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 57. ATRION: COMPANY SNAPSHOT
TABLE 58. ATRION: OPERATING SEGMENTS
TABLE 59. ATRION (QUEST MEDICAL): PRODUCT PORTFOLIO
TABLE 60. TERUMO: COMPANY SNAPSHOT
TABLE 61. TERUMO: OPERATING SEGMENTS
TABLE 62. TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. GLOBAL CARDIAC SURGICAL DEVICES MARKET, 2016-2023
FIGURE 2. GEOGRAPHICAL SNAPSHOT OF GLOBAL CARDIAC SURGICAL DEVICES MARKET, 2016-2023
FIGURE 3. CARDIAC SURGICAL DEVICES: MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 7. MARKET SHARE ANALYSIS, 2016
FIGURE 8. U.S. CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 9. CANADA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 10. MEXICO CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 11. GERMANY CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 12. FRANCE CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 13. UK CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 14. ITALY CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 15. SPAIN CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 16. REST OF EUROPE CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 17. CHINA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 18. JAPAN CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 19. INDIA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF ASIA-PACIFIC CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. LATIN AMERICA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. MIDDLE EAST CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. AFRICA CARDIAC SURGICAL DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 25. ABBOTT: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 26. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 27. ANGIODYNAMICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 28. ANGIODYNAMICS: REVENUE BY PRODUCT CATEGORY, 2016 (%)
FIGURE 29. ANGIODYNAMICS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 30. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 31. BOSTON SCIENTIFIC: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 32. BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 33. EDWARDS LIFE SCIENCE: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. EDWARDS LIFE SCIENCE: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 35. EDWARDS LIFE SCIENCE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. SORIN: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. SORIN: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. SORIN: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. GETINGE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. GETINGE: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 41. GETINGE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MEDTRONIC: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 44. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. ATRION: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. ATRION: REVENUE BY PRODUCT CATEGORY, 2016 (%)
FIGURE 47. ATRION: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. TERUMO: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. TERUMO: REVENUE BY SEGMENTS, 2016 (%)
FIGURE 50. TERUMO: REVENUE BY GEOGRAPHY, 2016 (%)